71
Participants
Start Date
August 4, 2022
Primary Completion Date
June 7, 2023
Study Completion Date
June 7, 2023
Reldesemtiv
Oral tablet
RSCI Education and Research Center Beaumount Hospital, Dublin
Concord Repatriation General Hospital, Concord
Uz Leuven Gasthuisberg Department of Neurology, Leuven
UMC Utrecht Department of Neurology, ALS Center, Utrecht
Royal Brisbane and Women's Hospital, Neurology Department, Herston
The Perron Institute, Nedlands
Hospital for Special Surgery, New York
"AOU Citta della Salute e della Scienza di Torino Universita degli Studi di Torino P.O. Mollinette - Dipartimento de Neuroscienze Rita Levi Montalcini", Torino
SUNY Upstate Medical University Institute for Human Performance, Syracuse
George Washington Medical Faculty Associates, Washington D.C.
IRCCS Istituto Auxologico Italiano Ospedale San Luca U.O. Neurologia e Stroke Unit, Milan
Johns Hopkins Outpatient Center, Baltimore
Virginia Commonwealth University, Henrico
Hospital San Rafael, Madrid
Atrium Health Neuroscience Institute, Charlotte
University of Florida, Jacksonville
Mayo Clinic Jacksonville, Jacksonville
University of South Florida - Carol and Frank Morsani Center for Advanced Health Care, Tampa
Indiana University IU Health Neuroscience Center, Indianapolis
Cleveland Clinic, Cleveland
Hospital Universitario y Politecnico La Fe, Valencia
Michigan Medicine, Ann Arbor
Henry Ford Hospital, Detroit
Froedtert Hospital - Department of Neurology, Milwaukee
The University of Kansas Medical Center, Kansas City
Neurology Associates, Lincoln
Texas Neurology, P.A., Dallas
University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora
St. Joseph's Hospital & Medical Center - Barrow Neurological Institute, Phoenix
University of California Irvine - ALS & Neuromuscular Center, Orange
California Pacific Medical Center - Forbes Norris MDA/ALS Research Center, San Francisco
University of Calgary - Heritage Medical Research Clinic, Calgary
University of Alberta, Edmonton
Stan Cassidy Centre for Rehabilitation, Fredericton
McMaster University, Hamilton
Ottawa Hospital Research Institute, Ottawa
Sunnybrook Health Sciences Centre, Toronto
Montreal Neurological Institute and Hospital, Montreal
University of Saskatchewan, Saskatoon
CHU de Quebec-Universite Laval, Québec
Studieenheten, Akademiskt Specialistcentrum, Stockholm
Lead Sponsor
Cytokinetics
INDUSTRY